Works matching IS 10781552 AND DT 2023 AND VI 29 AND IP 6
Results: 38
Retraction Notice: Adherence to treatment with oral antineoplastic therapy in outpatients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1541, doi. 10.1177/10781552231180699
- Publication type:
- Article
Ribociclib-induced pulmonary infiltrates in a patient with breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1537, doi. 10.1177/10781552231192005
- By:
- Publication type:
- Article
Poly(ADP-ribose) polymerase inhibitors in the treatment landscape of triple-negative breast cancer (TNBC).
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1467, doi. 10.1177/10781552231188903
- By:
- Publication type:
- Article
Azacitidine as a rare cause of reactive arthritis in a patient with acute myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1533, doi. 10.1177/10781552231180470
- By:
- Publication type:
- Article
Ribociclib-induced visual hallucination in a patient with metastatic breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1529, doi. 10.1177/10781552231180463
- By:
- Publication type:
- Article
An unusual case of checkpoint-inhibitor-induced pleuropericarditis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1525, doi. 10.1177/10781552231179369
- By:
- Publication type:
- Article
Liver cirrhosis following oxaliplatin-based adjuvant chemotherapy for rectal cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1520, doi. 10.1177/10781552231178685
- By:
- Publication type:
- Article
FOLFIRI-bevacizumab-induced acute toxic leukoencephalopathy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1516, doi. 10.1177/10781552231178680
- By:
- Publication type:
- Article
Combined use of pembrolizumab and lenvatinib: A review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1461, doi. 10.1177/10781552231178461
- By:
- Publication type:
- Article
Nivolumab-induced sensory ganglionopathy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1510, doi. 10.1177/10781552231177712
- By:
- Publication type:
- Article
Posterior reversible encephalopathy syndrome triggered by FLOT (5-fluorouracil, oxaliplatin, docetaxel, and calcium levofolinate) chemotherapy and thrombocytopenia (docetaxel and cisplatin) chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1503, doi. 10.1177/10781552231177597
- By:
- Publication type:
- Article
Extemporaneous compounding of dabrafenib and trametinib for cancer patients with feeding tubes.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1498, doi. 10.1177/10781552231175087
- By:
- Publication type:
- Article
Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1494, doi. 10.1177/10781552231174593
- By:
- Publication type:
- Article
Successful dasatinib therapy in newly diagnosed chronic myeloid leukemia in the setting of short bowel syndrome.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1489, doi. 10.1177/10781552231173441
- By:
- Publication type:
- Article
Severe hepatotoxicity during treatment with capmatinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1484, doi. 10.1177/10781552231173120
- By:
- Publication type:
- Article
Gemcitabine-associated DRESS syndrome: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1480, doi. 10.1177/10781552231167531
- By:
- Publication type:
- Article
Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1404, doi. 10.1177/10781552221126102
- By:
- Publication type:
- Article
Corrigendum to "Anti-cancer medicine shortages in an oncology tertiary hospital of Pakistan: A five-year retrospective study".
- Published in:
- 2023
- Publication type:
- Correction Notice
Medication errors in cancer therapy: Reports from German hospital pharmacists between 2008 and 2019.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1443, doi. 10.1177/10781552221135130
- By:
- Publication type:
- Article
Comparative cost savings of biosimilar and dose rounding utilization in oncology care.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1437, doi. 10.1177/10781552221134257
- By:
- Publication type:
- Article
Management of chemotherapy-induced febrile neutropenia and use of granulocyte colony-stimulating factor in patients with soft tissue or bone sarcoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1428, doi. 10.1177/10781552221131901
- By:
- Publication type:
- Article
Economic burden in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), with or without brain metastases, receiving first-line ALK inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1418, doi. 10.1177/10781552221126174
- By:
- Publication type:
- Article
A comparison of hypersensitivity reactions between intravenous and intramuscular applications of native E. coli asparaginase in children with acute lymphoblastic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1454, doi. 10.1177/10781552231164503
- By:
- Publication type:
- Article
Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1398, doi. 10.1177/10781552221125871
- By:
- Publication type:
- Article
Inpatient utilization of immune checkpoint inhibitors and clinical outcomes.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1392, doi. 10.1177/10781552221123967
- By:
- Publication type:
- Article
Assessment of chemotherapy-related educational needs of colorectal cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1387, doi. 10.1177/10781552221122782
- By:
- Publication type:
- Article
Real-world analysis of tumor lysis syndrome in patients started on venetoclax combination for acute myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1326, doi. 10.1177/10781552221118635
- By:
- Publication type:
- Article
Effectiveness of antiemetic in reducing chemotherapy-induced nausea and vomiting in adult patients; An oncology center experience.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1317, doi. 10.1177/10781552221118634
- By:
- Publication type:
- Article
Combination of available topical beta-blockers and antibiotic ointment for epidermal growth factor receptor tyrosine kinase inhibitor-induced paronychia and pseudopyogenic granulomas in Taiwan.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1374, doi. 10.1177/10781552221122051
- By:
- Publication type:
- Article
Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1381, doi. 10.1177/10781552221122058
- By:
- Publication type:
- Article
Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1361, doi. 10.1177/10781552221122026
- By:
- Publication type:
- Article
Contribution of an anticancer drug compounding robot in reducing the risks of manual preparation in a hospital pharmacy unit specialized in oncology.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1334, doi. 10.1177/10781552221118846
- By:
- Publication type:
- Article
Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendations.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1343, doi. 10.1177/10781552221119797
- By:
- Publication type:
- Article
Impact of oral chemotherapy pharmacists on cost avoidance of oral oncolytics in an integrated health system.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1369, doi. 10.1177/10781552221122034
- By:
- Publication type:
- Article
Protective effects of Panax ginseng against doxorubicin-induced cardiac toxicity in patients with non-metastatic breast cancer: A randomized, double-blind, placebo-controlled clinical trial.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1306, doi. 10.1177/10781552221118530
- By:
- Publication type:
- Article
Impact of single-nucleotide variants and nutritional status on population pharmacokinetics of Doxorubicin, and its effect on cardiotoxicity in children with leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1290, doi. 10.1177/10781552221117810
- By:
- Publication type:
- Article
Corrigendum to Role of sacituzumab govitecan in solid tumors.
- Published in:
- 2023
- Publication type:
- Correction Notice
Erratum to Evaluation of antibiotic appropriateness at an outpatient oncology centre.
- Published in:
- 2023
- Publication type:
- Correction Notice